Learn about the “four-pillar” approach to managing diabetes in chronic kidney disease, highlighting the significant renal and cardiovascular protective benefits of SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRAs while emphasising a return to foundational therapies like insulin in advanced stages of the disease.
Presented by Dr Chanel Chong, a Nephrologist at the Norwest Private Hospital.
This presentation was recorded at a Norwest Private Hospital Men’s Health Masterclass in October 2025.
691d256059025-bpthumb.png){kind=avatar}